Flagship Pioneering Inc. Portfolio Holdings

Flagship Pioneering Inc.

  • $334 Million
  • Q4 2024

Flagship Pioneering Inc. has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $334 Million distributed in 10 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Moderna, Inc. with a value of $193M, Foghorn Therapeutics Inc. with a value of $59.8M, Sana Biotechnology, Inc. with a value of $40.8M, Omega Therapeutics, Inc. with a value of $21.9M, and Seres Therapeutics, Inc. with a value of $19.2M.

Examining the 13F form we can see an decrease of $255M in the current position value, from $589M to 334M.

Flagship Pioneering Inc. is based out at Cambridge, MA

Below you can find more details about Flagship Pioneering Inc. portfolio as well as his latest detailed transactions.

Portfolio value $334 Million
Healthcare: $334 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$159M
$59.8 Million 17.9% of portfolio
12,674,120
Q4 2020 New
$90.6M
$19.2 Million 5.74% of portfolio
23,117,045
Q3 2022 Added 60.77%

Summary

  • Portfolio
  • No. of Stocks 10
  • Current Value $334 Million
  • Prior Value $589 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Flagship Pioneering Inc. Portfolio

Follow Flagship Pioneering Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Pioneering Inc., based on Form 13F filings with the SEC.

News

Stay updated on Flagship Pioneering Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email